Arbutus Biopharma Corp. (ABUS)
4.29
-0.16
(-3.60%)
USD |
NASDAQ |
Mar 27, 16:00
4.30
+0.01
(+0.23%)
After-Hours: 20:00
Arbutus Biopharma Shareholders Equity (Quarterly) : 76.58M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna, Inc. | 8.65B |
| Merck & Co., Inc. | 52.61B |
| Pfizer Inc. | 86.48B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.62M |
| Total Liabilities (Quarterly) | 18.04M |
| Debt to Equity Ratio | 0.0547 |
| Current Ratio | 15.73 |
| Net Debt Paydown Yield | 0.06% |